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Abstract
Cellular adaptation to changes in environmental osmolarity is crucial for cell survival. In Dictyostelium, STATc is a key
regulator of the transcriptional response to hyperosmotic stress. Its phosphorylation and consequent activation is controlled
by two signaling branches, one cGMP- and the other Ca2+-dependent, of which many signaling components have yet to be
identified. The STATc stress signalling pathway feeds back on itself by upregulating the expression of STATc and STATc-
regulated genes. Based on microarray studies we chose two tyrosine-kinase like proteins, Pyk3 and Phg2, as possible
modulators of STATc phosphorylation and generated single and double knock-out mutants to them. Transcriptional
regulation of STATc and STATc dependent genes was disturbed in pyk32, phg22, and pyk32/phg22 cells. The absence of
Pyk3 and/or Phg2 resulted in diminished or completely abolished increased transcription of STATc dependent genes in
response to sorbitol, 8-Br-cGMP and the Ca2+ liberator BHQ. Also, phospho-STATc levels were significantly reduced in pyk32
and phg22 cells and even further decreased in pyk32/phg22 cells. The reduced phosphorylation was mirrored by a
significant delay in nuclear translocation of GFP-STATc. The protein tyrosine phosphatase 3 (PTP3), which dephosphorylates
and inhibits STATc, is inhibited by stress-induced phosphorylation on S448 and S747. Use of phosphoserine specific
antibodies showed that Phg2 but not Pyk3 is involved in the phosphorylation of PTP3 on S747. In pull-down assays Phg2
and PTP3 interact directly, suggesting that Phg2 phosphorylates PTP3 on S747 in vivo. Phosphorylation of S448 was
unchanged in phg22 cells. We show that Phg2 and an, as yet unknown, S448 protein kinase are responsible for PTP3
phosphorylation and hence its inhibition, and that Pyk3 is involved in the regulation of STATc by either directly or indirectly
activating it. Our results add further complexities to the regulation of STATc, which presumably ensure its optimal activation
in response to different environmental cues.
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Introduction
Virtually all cells, even individual cells in multi-cellular
organisms, are subjected to changes in the osmotic environment
that are sometimes extremely rapid. In order to survive cells have
to sense these changes and elicit an appropriate response that
allows them to adapt. When Dictyostelium discoideum cells are faced
with a hypertonic environment a complex response is triggered. It
starts with signal sensing and transduction and leads to changes in
cell shape, the cytoskeleton, transport processes, metabolism and
gene expression [1,2]. STATc (Signal Transducer and Activator of
Transcription c), one of the four STAT proteins encoded by D.
discoideum, is an important mediator of the transcriptional response
to hyperosmolarity as it regulates 20% of the induced genes [2,3].
In mammals, STAT1 and STAT3 are normally activated by
cytokines but can also be activated by hyperosmotic stress [4].
Mammalian STATs are generally activated by JAK (Janus kinase)
family members through tyrosine phosphorylation [5]. In contrast,
D. discoideum does not encode a JAK ortholog. However, the
genome encodes a large number of tyrosine-kinase like (TKL)
proteins which constitute STATc kinase candidates [6]. Hyperos-
motic shock is suggested to activate two parallel, oppositely acting
pathways, which are under control of the second messengers
cGMP and Ca2+, respectively, and ultimately cause phosphoryla-
tion of STATc on Tyr922 [7]. Phosphorylated STATc dimerises,
translocates to the nucleus, and controls gene expression. Within
the former pathway, STATc can be activated by the membrane-
permeable cGMP analogue 8-Br-cGMP, which acts on the
cGMP-binding protein C (GbpC), a founding member of the
ROCO family of protein kinases that also contain LRRK2, the
protein most frequently mutated in familial Parkinson’s disease
[3,8]. The activation of STATc by 8-Br-cGMP but not by osmotic
stress is lost in a gbpC2 strain. Furthermore, hyperosmotic stress-
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induced tyrosine phosphorylation of STATc was still observed in a
D. discoideum mutant, wherein both known guanylate cyclases
(GCA and sGC) were disrupted [3]. This can be explained by the
parallel activation of the Ca2+ branch in response to hyperosmo-
larity [7]. Recently it was shown that the TKL protein Pyk2
directly phosphorylates STATc on Tyr922 in response to the
chlorinated hexaphenone DIF-1, which activates STATc during
development [7,9–11].
Another essential player in the complex regulation of STATc is
the constitutively active protein tyrosine phosphatase 3 (PTP3)
[7,12]. PTP3 is localised in the cytosol of unstimulated cells and
accumulated at endosomes, when cells were subjected to
hyperosmotic stress [13]. Overexpression of PTP3 inhibited
STATc tyrosine phosphorylation, whereas overexpression of a
dominant inhibitor of PTP3 led to constitutive STATc phosphor-
ylation and nuclear localisation [12]. An ortholog of the
mammalian E3 ubiquitin ligase Cbl, CblA, was found to act as
a positive regulator of STATc phosphorylation by down-regulat-
ing PTP3 [14]. Exposure to hyperosmotic stress or to agents that
elevated intracellular Ca2+ levels induced phosphorylation of S448
and S747 of PTP3 and inhibited its enzymatic activity [7].
Here we characterise two further modulators of the STATc
signalling cascade, the TKL proteins Pyk3 and Phg2, which were
selected based on previous microarray results and BLAST searches
[2]. We analysed single knock-out mutants for pyk3 and phg2, a
double knock-out mutant of both genes, as well as GFP-STATc,
Myc-PTP3 and Myc-Phg2 overexpressing Ax2 wild-type and
mutant cells with respect to transcriptional regulation, STATc and
PTP3 phosphorylation, and STATc nuclear translocation. We
present evidence that both TKL proteins modulate STATc-
signalling and that Phg2 but not Pyk3 acts as a PTP3 inhibitor.
Materials and Methods
Strains and Cell Culture
D. discoideum Ax2 wild-type and mutant cells (Table 1) were
grown at 21uC either on SM agar plates with Klebsiella aerogenes as
food source [15] or in Ax2-medium (for 1 l: 14.3 g bacteriological
peptone, 7.15 g yeast extract, 18 g maltose, 0.62 g Na2H-
PO462H20, 0.49 g KH2PO4, pH 6.7), that contained 40 mg/ml
dihydrostreptomycinsulfate and in the case of mutant strains in
addition 10 mg/ml blasticidin or 10 mg/ml G418, on plates
(90 mm diameter) or in Erlenmeyer flasks with shaking at
160 rpm [16]. For cell biological work, cultures were harvested
at a density of 3–46106 cells/ml. For treatment with 200 mM
sorbitol, 20 mM 8-Br-cGMP, 30 mM BHQ or 5 mM thapsigargin,
cells were washed twice with Soerensen phosphate buffer (2 mM
Na2HPO4, 14.6 mM KH2PO4, pH 6.0), resuspended in the same
buffer at 26107 cell/ml, and developed under shaking at 200 rpm
for 4 hours. Treatment was performed for 5 to 15 minutes
depending on the assay.
Molecular Biological Methods
All Dictyostelium mutant strains were generated in the AX2
background. Gene replacement constructs were generated in the
pLBPLP vector where the blasticidin resistance (bsr) cassette is
flanked by loxP sites [17]. For the phg22 construct, a PCR
amplified fragment of 507 bp (59-homology arm; forward primer:
59-GCGGGATCCGGATGACCAACAACCATTAC-39; reverse
primer: 59-GCGCTGCAGACGCCCAAAATTAAGCTTTAG-
39) was cloned into the BamHI and PstI sites and a 670 bp
fragment (39-homology arm; forward primer: 59-
GCGAAGCTTCTAGATGTTGGGATGAGAACCCTGAC-39;
reverse primer: 59-GCGGTCGACCATTTAGAGTGCTTT-
TATTACCTTC-39) into the HindIII and SalI sites of the vector.
Upon homologous recombination of the ‘restriction enzyme’
linearized targeting construct, the genomic region of the phg2 gene
encompassing the TKL domain was replaced by the bsr cassette
(Fig. S1). Similarly, the pyk32 construct was created. A PCR
amplified fragment of 551 bp (59-homology arm; forward primer:
59- CGCGGATCCGAAGGTATGGATCCGATATTGGC -39;
reverse primer: 59- CGCCTGCAGGCAGGTGGTAAATTTG-
TAATTG-39) was cloned into the BamHI and PstI sites and a
656 bp fragment (39-homology arm; forward primer: 59-
CGCAAGCTTCTTTAGGTATGGAACATCTTC-39; reverse
primer: 59- CGCGTCGACCTAACTATCAACCTCTTCATC-
39) into the HindIII and SalI sites of the vector. Upon homologous
recombination, the bsr cassette of the targeting construct replaced
2.37 kbp of the pyk3 gene thereby disrupting part of the TKL
domain (Fig. S1). To generate the pyk32/phg22 double knock-out
strain, the pyk32 strain was first transformed with the pDEX-
NLS-cre vector to transiently express the cre recombinase [18].
After removal of the loxP flanked bsr cassette, blasticidin sensitive
pyk32 cells were transformed with the phg22 construct. An
independent pyk32 knock-out strain was generated by Tsuyoshi
Araki (University of Dundee). The two knock-out mutants were
exchanged between the two laboratories and compared in some of
the real time PCR and STATc phosphorylation experiments. The
plasmids for expression of Myc-PTP3 and GFP-STATc in D.
discoideum cells have been described elsewhere [3,12]. The plasmids
were introduced into Ax2 wild type cells and the different mutants
by electroporation. For the Myc-Phg2 construct the sequence
encoding aa 207–1159 of Phg2 was cloned into the Myc-PTP3
expression vector by replacing the PTP3 coding sequence and the
plasmid was transformed into Ax2 wild-type cells. Transformants
were selected in the presence of either 10 mg/ml blasticidin S or
G418 and identified by PCR screening of resistant clones followed
by visual inspection under a fluorescence microscope and/or
immunological detection of the expressed proteins in Western
blots. RNA isolation and real time PCR was essentially done as
described [19]. The used primers were purchased from Metabion
Corp. (Munich, Germany; Table 2).
Expression and Purification of Recombinant Proteins
For generation of Pyk3- and Phg2-specific polyclonal antibodies
(pAbs), cDNA sequences encoding amino acids 1020–1309 of
Pyk3 and 656–706 of Phg2 were amplified by PCR and cloned
into the Escherichia coli expression vector pGEX-6-P-1 (GE
Healthcare Corp.). The fusion proteins were expressed in E. coli
XL1-blue, purified using glutathione agarose beads, released from
the beads through cleavage with PreScission protease, and used for
the immunization of rabbits (BioGenes GmbH, Berlin, Germany).
For pull-down assays amino acids 207–1159 of Phg2 were
expressed, purified, and eluted with glutathione. For in vitro
PTP3 phosphorylation we used bacterially expressed GST-
PTP3DCS [12].
SDS PAGE and Western Blotting
SDS-PAGE and Western blotting were essentially performed as
described [20,21]). Proteins of total cell lysates from 2–46105 cells
were separated by SDS-PAGE and electrophoretically transferred
to a nitrocellulose membrane with a wet blot apparatus at 10 V
overnight. Phg2 and Pyk3 polyclonal antibodies were used at a
1:100 and 1:40,000 dilutions, respectively. GFP was detected with
mAb K3-184-2 [22], total STATc with mAb 7H3 and Tyr922-
phosphorylated STATc with mAb CP22 [10]. Myc-tagged
proteins were detected with anti myc mAb 9E10 at a 1:1,000
dilution. Ser448- and Ser747-phosphorylated PTP3 were monitored
Pyk3 and Phg2 Regulate STATc Phosphorylation
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by using specific PTP3 phospho S448 and S747 antibodies [7].
Secondary antibodies used were anti-mouse and anti-rabbit IgG
conjugated with peroxidase (POD) (Sigma, Germany) followed by
chemiluminescence detection. Images were recorded and analysed
using the Fluorchem SP imaging system (Alpha Innotech, USA).
Fluorescence Microscopy
Fluorescence microscopy studies were carried out using Ax2
wild-type, pyk32, phg22, and pyk32/phg22 cells ectopically
expressing GFP-STATc [3]. 16106 cells were collected, washed
twice with Soerensen phosphate buffer, resuspended in 100 ml of
the same buffer, and allowed to settle for 15 min on acid-washed
glass coverslips (18 mm diameter). The cells were treated with
100 mM sorbitol for 0 to 8 minutes, immediately fixed with pre-
chilled (220uC) methanol in a petri dish, and incubated at 220uC
for 10 min. The coverslips were then washed three times with
500 ml PBG (1x PBS, pH 7.4, 0.5% bovine serum albumin, 0.1%
fish gelatine buffer), mounted onto glass slides with the cells facing
downwards, sealed with gelvatol, and stored in the dark at 4uC
overnight. Images of fixed cells were recorded with the inverted
fluorescence microscope (LEICA DMI 6000 B) at 488 nm
excitation and 500–550 nm emission and processed using the
Leica MM AF software.
Pull-Down Experiments
Myc-PTP3 was expressed in phg22 cells. 1–66107 cells were
treated with 200 mM sorbitol for 15 minutes and lysed in 1 ml
mNP40 lysis buffer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl,
1% NP-40, 50 mM NaF, 2 mM EDTA, 2 mM Na-pyrophos-
phate, complete EDTA-free protease inhibitor cocktail (1 tablet/
50 ml; Roche GmbH)) for 10 min on ice. The cell lysate was
centrifuged at 7,0006 g for 10 min, the supernatant was pre-
cleared by incubation with Dynabeads Protein G (Life technolo-
giesTM) for 30 min at 4uC with rotation, followed by centrifugation
at 5006 g for 1 min. The cleared supernatant was incubated for
30 min at 4uC with 2 mg Myc antibody (mAb 9E10) and then for
further 60 min with the Dynabeads Protein G. After incubation
the Dynabeads were washed four times with EDTA free mNP40-
buffer. 5–10 mg bacterially expressed and purified GST-Phg2 were
released from glutathione agarose beads through incubation with
20 mM glutathione, and added in pull-down buffer (20 mM
Hepes/NaOH, pH 7.4, 10 mM MgCl2, 0.02% NP-40, 30 mM
NaCl, 1 mM Glycerol-2-phosphate, 1 mM DTT containing
complete EDTA-free protease inhibitor cocktail (1 tablet/50 ml)
and 0.2 mM ATP) to the Dynabeads followed by incubation for
2 h at 4uC. For reverse pulldown myc-PTP3 was immunopurified
from phg22 cells as above and eluted from the Dynabeads by a
pH shift (50 mM Glycin, pH 2.8). The eluted Myc-PTP3 was then
incubated in pull-down buffer together with 50 ml GST-Phg2
coated glutathione agarose beads. In both protocols the beads
were washed 5–10 times with washing buffer (50 mM Tris/HCl,
pH 8.0, 150 mM NaCl), eluted in 50 ml 3 x SDS sample buffer,
boiled for 3 minutes, and the proteins were separated by SDS-
PAGE followed by Western blot analysis using anti Myc, anti
Phg2, and anti GST-antibodies.
Table 1. D. discoideum mutant strains used in this study.
Strains Summary Reference
pyk32 Pyk3 null mutant this study
phg22 Phg2 null mutant this study
pyk32/phg22 Pyk3/Phg2 double null mutant this study
STATc2 STATc null mutant [10]
Ax2/[act15]:Myc-PTP3 Overexpression of Myc-PTP3 in Ax2 this study
phg22/[act15]:Myc-PTP3 Overexpression of Myc-PTP3 in a Phg2 null background this study
pyk32/[act15]:Myc-PTP3 Overexpression of Myc-PTP3 in a Pyk3 null background Tsuyoshi Araki, unpublished
Ax2/[act15]:Myc-Phg2 Overexpression of Myc-Phg2 in Ax2 this study
Ax2/[act15]:GFP-STATc Overexpression of GFP-STATc in Ax2 this study
pyk32/[act15]:GFP-STATc Overexpression of GFP-STATc in a Pyk3 null background this study
phg22/[act15]:GFP-STATc Overexpression of GFP-STATc in a Phg2 null background this study
pyk32/phg22/[act15]:GFP-STATc Overexpression of GFP-STATc in a Pyk3/Phg2 double null background this study
doi:10.1371/journal.pone.0090025.t001





DDB_G0293532 dstc Forward: 59-CAATTACTTTGTGGCACTCG-39
Reverse: 59-CCAAATTTGAGGGTTACTGG-39
DDB_G0282145 ptpC Forward: 59-ACCGATATGGGTATTCGTTC-39
Reverse: 59-TGTTGTGGTGGGAATTTTAG-39
DDB_G0283385 pyk1 Forward: 59-AAGTTGGCTTTGGATATTGC-39
Reverse: 59-GCCATGTAGGGAATACAACC-39
DDB_G0285321 pyk2 Forward: 59-CTGTACACACTACTAGTGGTGG-39
Reverse: 59-CTACCTCTAGGTCTCATATGAG-39
DDB_G0289001 pyk3 Forward: 59-TTTTATGGGTGCCTGTATTG-39
Reverse: 59-TCATCGCTTAAAGTTGTTGC-39
DDB_G0283699 phg2 Forward: 59-GAGAACCCTGACAAAAGACC-39
Reverse: 59-GAGGAAGAAGGCACAACAAC-39
DDB_G0282895 morn Forward: 59-ATTGGATCACCACCATTACC-39
Reverse: 59-TCATCACCACTTGAAGCAAC-39
DDB_G0293416 abcB1 Forward: 59-CAGCTATCAATGTTTCAGGTG-39
Reverse: 59-CCACGATACCAAACTGGATCC-39
Oligonucleotide primers were designed on the basis of sequence information
and purchased from Metabion Corp. (Munich, Germany).
doi:10.1371/journal.pone.0090025.t002
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Results
STATc Differentially Regulates Genes Encoding Signalling
Proteins
STATc is a key regulator of the transcriptional response to
hyperosmotic shock and regulates approximately 20% of the
differentially expressed genes [2]. We found that a small fraction of
the STATc dependent genes was already differentially regulated
15 minutes after subjecting the cells to hyperosmotic conditions.
Most interesting of these genes were STATc itself, the STATc
inhibitor PTP3, and five genes encoding TKL proteins including
the DIF-regulated STATc activator Pyk2 (Table 3). We confirmed
their differential regulation by real time PCR by comparing the
expression profiles of treated versus untreated Ax2 wild-type and
STATc2 cells (Fig. 1). All of these genes showed significant
upregulation upon treatment with sorbitol in Ax2 wild-type cells
which was lost in the STATc2 strain.
The D. discoideum genome does not encode an obvious ortholog
of the mammalian JAKs and the question was, whether the
microarray and real time PCR results could point us to upstream
regulators of STATc. The upregulation of STATc, PTP3, and
Pyk2 upon sorbitol treatment suggested the existence of a positive
feedback loop also for other genes encoding proteins of the STATc
signalling cascade. Based on the assumption of i) a positive
transcriptional feedback loop, ii) their STATc-dependent differ-
ential regulation, and iii) the presence of a tyrosine-kinase-like
catalytic domain, we considered Pyk1, Pyk3, Phg2, and the
MORN kinase as potential upstream regulators of STATc. The
Pyk2 kinase was excluded from further analysis because its genetic
ablation has been shown to cause only a one minute delay in
sorbitol-induced STATc activation [11]. BLAST searches against
the D. discoideum proteome with a human JAK protein sequence
(NP_002218) revealed highest sequence similarity with Pyk3.
Furthermore, it was previously shown that Phg2 interacts with
Rap1-GTP which has been linked to the response to sorbitol [23].
We therefore decided to further analyse the cellular functions of
Pyk3 and Phg2 with respect to STATc signalling. They encode
TKL proteins of 1338 and 1387 amino acids, respectively. Pyk3
contains a long N-terminal region of mostly low compositional
complexity and two C-terminal protein kinase domains, of which
the first one is predicted to be a pseudokinase as is the case for
members of the JAK family (Fig. S2). In contrast, Phg2 has an N-
terminal coiled coil region followed by a ras binding domain
(RBD, aa 594–667), a protein kinase domain (aa 802–1074), and
long stretches of low compositional complexity in the remaining
sequence (Fig. S2; [23]). We generated knock-out mutants for
Pyk3, Phg2, and a double knock-out for both genes and verified
them by reverse transcription (RT) PCR and Western blot analysis
(Fig. S1 and S3). An independent pyk32 knock-out strain was
generated by Tsuyoshi Araki (University of Dundee). We
exchanged the two Pyk3 knock-out mutants and in all experiments
where we used them in parallel we obtained similar results (data
not shown).
Pyk3 and Phg2 are Part of the STATc Signalling Cascade
We first investigated whether Pyk3 and/or Phg2 are required
for stress-induced transcription of STATc-regulated genes. Ax2
wild-type, the STATc2, pyk32, phg22, and pyk32/phg22 strains
were treated with 200 mM sorbitol or left untreated, RNA was
isolated, reverse transcribed, and quantitative real time PCR was
performed for dstc, phg2, pyk3, ptpc, and abcB1 (ABC transporter B
family protein) as control. abcB1 was previously found to be
differentially regulated independently of STATc in response to
osmotic stress [2]. All of these genes except abcB1 were
upregulated in Ax2 wild-type cells but not differentially regulated
in the STATc2 cells. This is consistent with previous microarray
and quantitative real time PCR results (Table 3, Fig. 1, [2]). In
contrast, the sorbitol-induced upregulation of all selected genes
was approximately two-fold lower in the pyk32 cells indicating the
need for Pyk3 for a full transcriptional response to sorbitol. In
phg22 and pyk32/phg22 cells the sorbitol-induced expression of
the selected genes was lost. This showed that the presence of Phg2
is essential for the transcriptional regulation of these STATc
dependent genes (Fig. 2A).
It has been previously shown that two signalling branches
converge on STATc in response to hypertonicity, which are under
control of the second messengers cGMP and Ca2+, respectively
Figure 1. Real time PCR confirms STATc-dependent transcriptional activation of selected genes. The differential expression of seven
selected genes (see Table 3) in Ax2 wild-type (black bars) and STATc2 (white bars) cells in response to treatment with 200 mM sorbitol for 15 minutes
was analysed by quantitative real time PCR. The data are expressed as means of fold change in comparison to untreated cells. Fold changes and
standard deviations of six measurements from three independent experiments are shown. N/A: not applicable.
doi:10.1371/journal.pone.0090025.g001
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[7]. We therefore treated the cells with 8-Br-cGMP, a membrane-
permeable cGMP analogue and a known activator of STATc
[3,24]. The results were principally similar to the sorbitol
treatment, however, the overall fold changes for Ax2 and pyk32
cells were generally lower except for the upregulation of phg2
indicating that the activation of the cGMP branch is not sufficient
for full transcriptional activation (Fig. 2B). We next investigated
the role of Ca2+ in the differential regulation of these genes by
treating Ax2 wild-type, pyk32, phg22, and pyk32/phg22 cells
with tBuBHQ (BHQ), which causes an increase in cytosolic Ca2+
levels. The real time PCR results showed that only dstc but not the
other genes were upregulated under these conditions in Ax2 wild-
type cells, but not in the mutants (Fig. 2C). The fold changes were
again, as with 8-Br-cGMP, significantly lower when compared to
the response to sorbitol. In addition, we found a down-regulation
for phg2 in Ax2 and pyk32 cells and for pyk3 in Ax2 wild-type cells.
We obtained similar results when we treated the cells with
thapsigargin (data not shown). In summary, these results show that
activation of both, the cGMP and the Ca2+, branches are needed
for a full transcriptional response of STATc and the investigated
STATc dependent genes. They also show that expression of
STATc can be induced by a rise in cGMP as well as Ca2+, while
induction of phg2, pyk3 and ptp3 needs activation of the cGMP
branch. Interestingly, the observed fold changes in response to
sorbitol in AX2 cells were generally higher than the sum of these
changes in response to 8-Br-cGMP and BHQ. This is very obvious
for pyk3 where we see a smaller upregulation in response to 8-Br-
cGMP as compared to sorbitol and a downregulation in response
to BHQ. The discrepancy in the fold change in response to
sorbitol versus activation of the single branches can be explained if
we assume a crosstalk between the two branches where e.g.
activation of the cGMP branch would somehow exert an
inhibitory effect on the Calcium branch. Alternatively, sorbitol
might activate yet another, so far unknown signalling pathway.
STATc Phosphorylation is Reduced in pyk32, phg22 and
pyk32/phg22 Cells
When D. discoideum cells are exposed to 200 mM sorbitol
STATc is activated by phosphorylation on Tyr922. In the absence
of hyperosmotic conditions STATc phosphorylation can also be
induced by 8-Br-cGMP and BHQ [3]. We tested the potential
involvement of Pyk3 and Phg2 in STATc activation by analysing
STATc phosphorylation levels on Tyr922 in Ax2, pyk32, phg22,
and pyk32/phg22 cells. For quantitation of phospho- and total
STATc we used the STATc phosphorylation-specific monoclonal
antibody CP22 and the total STATc antibody 7H3 [10]. Cells
were treated with either sorbitol or 8-Br-cGMP or BHQ and
Western Blot analyses were performed. In Ax2 cells, we observed a
strong induction of STATc phosphorylation upon sorbitol
treatment. In contrast, pyk32 and phg22 cells showed significantly
lower levels of phosphorylated STATc and the pyk32/phg22
double mutant displayed a further decrease but not a complete
abolishment of STATc phosphorylation (Fig. 3A). Densitometry
analyses of three independent experiments revealed in the single
mutants an approximately two-fold and in the double mutant an
approximately five-fold lower level of STATc phosphorylation
(Fig. 3D; STATc phosphorylation of sorbitol treated Ax2 cells is
set to 1). Next we stimulated the different strains with 8-Br-cGMP
and obtained similar results as upon sorbitol treatment. Specifi-
cally, we observed an approximately two-fold reduction of p-
STATc in the single mutants and an approximately five-fold
reduction in the double mutant. For all strains we found a clear
induction of STATc phosphorylation upon treatment though the
level of p-STATc was in this series of experiments already quite
high in untreated Ax2 cells (Fig. 3B and E). To investigate whether
a rise in intracellular Ca2+ could induce STATc phosphorylation
in Ax2 and the mutant strains we treated the cells with BHQ. We
observed a clear induction of STATc phosphorylation in Ax2 cells.
In comparison to Ax2 total p-STATc levels were extremely low in
pyk32, phg22, and pyk32/phg22 in response to BHQ, however,
phosphorylation of STATc still appeared to be induced upon
treatment (Fig. 3C and F). It should be noted that, although
absolute p-STATc levels upon treatment were always significantly
lower in the mutant strains as compared to wild-type, treatment
with either sorbitol or 8-Br-cGMP or BHQ still appeared to
induce phosphorylation for STATc in all strains. A measure of the
induction is the ratio of p-STATc in treated versus untreated cells.
It clearly shows that for all strains phosphorylation of STATc is
induced for all three conditions (Fig. 3G–I). However, it is at
present not possible to make a firm statement if in addition to the
absolute levels also the relative induction of STATc phosphory-
lation was changed in the mutant strains because the standard
deviations of the individual experiments were rather high. In
summary we conclude from these results that Pyk3 and Phg2
somehow contribute to STATc phosphorylation in response to
hyperosmotic conditions. The further decrease of STATc phos-
phorylation in the double mutant in comparison to the single
knock-out mutants in response to sorbitol and 8-Br-cGMP suggests
that Pyk3 and Phg2 act in parallel.
Table 3. Selection of STATc regulated genes.
dictyBase ID Gene Name Gene Product
DDB_G0293532 dstC signal transducer and activator of transcription (STAT) family protein DstC ( = STATc)
DDB_G0282145 ptpC protein tyrosine phosphatase PTP3
DDB_G0283385 pyk1 Pyk1/SplA tyrosine kinase-like protein (TKL group)
DDB_G0285321 pyk2 Pyk2/SplB tyrosine kinase-like protein (TKL group)
DDB_G0289001 pyk3 Pyk3/PkyA tyrosine kinase-like protein (TKL group)
DDB_G0283699 phg2 Phg2 tyrosine kinase-like protein (TKL group)
DDB_G0282895 DDB_G0282895 MORN repeat-containing protein, tyrosine kinase-like protein (TKL group)
Ax2 and STATc2 cells were treated for 15 min with 200 mM sorbitol or left untreated and differentially regulated genes were identified by microarray analysis [2].
Depicted are dstc, ptpc and five genes encoding TKL proteins.
doi:10.1371/journal.pone.0090025.t003
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Nuclear Translocation of STATc is Delayed in Mutant
Strains
Hyperosmotic conditions trigger STATc phosphorylation and
dimerization followed by nuclear translocation enabling STATc to
differentially regulate the expression of a large number of target
genes [2,3]. We expressed GFP-STATc in Ax2 wild-type, pyk32,
phg22, and pyk32/phg22 cells. Western blot analysis using a
specific monoclonal GFP antibody showed that all strains
expressed GFP-STATc at similar levels, with exception of the
pyk32/phg22 strain where GFP-STATc levels were lower (Fig.
S4). Nuclear translocation of GFP-STATc was induced by
treatment with sorbitol for different time intervals and analysed
microscopically. Assessment of GFP-STATc nuclear translocation
after 3 and 8 minutes of treatment indicated a delay in the mutant
strains (Fig. 4A). Quantitative analyses of two independent
experiments clearly confirmed this phenotype. For example at
the three minutes time point GFP-STATc is found in the nucleus
in about 50% of Ax2 wild-type cells. In contrast, in the pyk32 and
phg22 mutants full nuclear translocation of GFP-STATc was only
seen in around 1–5% of the cells. For around 30–50% of the cells
we observed partial translocation and in the remaining 50–70%
GFP-STATc was still completely cytosolic. The delay was even
more pronounced in the pyk32/phg22 cells as GFP-STATc was
still found in the cytosol in almost 80% of the cells at this time
point (Fig. 4B). Nuclear translocation of GFP-STATc in the three
Figure 2. Pyk3 and Phg2 are required for full transcriptional activation of STATc-dependent genes. Real time PCR analysis of selected
genes was carried out with cDNAs from untreated cells and from cells treated for 15 minutes with either 200 mM sorbitol (A), 20 mM 8-Br-cGMP (B) or
30 mM BHQ (C). The differential expression was investigated in Ax2 wild-type, pyk32, phg22, pyk32/phg22, and STATc2 cells upon treatment with
sorbitol and 8-Br-cGMP (A, B) or in Ax2 wild-type, pyk32, phg22, and pyk32/phg22 cells upon treatment with BHQ (C). The data are expressed as
means of fold change in comparison to untreated cells. A students t-test was performed and significance values were calculated: p-value,0.05 = */&;
p-value,0.01 = **/&&; p-value,0.001 = ***/
&&&
. Fold changes and standard deviations of six measurements from three independent experiments
are shown. *Statistically significant changes, compared with AX2 cells. &Statistically significant changes, compared with pyk32 cells. N/A: not
applicable.
doi:10.1371/journal.pone.0090025.g002
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mutant strains was also delayed at the other time points (Fig. 4B;
Fig. S5). The results show that Pyk3 and Phg2 are required for
efficient nuclear translocation of STATc in response to sorbitol.
The further delay of nuclear translocation of STATc in the double
mutant in comparison to the single knock-out mutants again
suggests that Pyk3 and Phg2 act in parallel.
Phg2 but not Pyk3 is Upstream of PTP3
The protein tyrosine phosphatase PTP3 is crucial for the
balance between phosphorylated and dephosphorylated STATc.
PTP3 is constitutively active in its non-phosphorylated form and
removes the phosphate from Tyr922 of STATc. Upon hyperos-
motic stress, PTP3 becomes phosphorylated on serines 448 and
747 (Fig. 5A) [7]. This results in a decrease of its enzymatic activity
and shifts the balance to tyrosine phosphorylation and activation
of STATc [7,12,13]. Our results so far show that Pyk3 and Phg2
are part of the STATc signalling cascade. Their cellular functions
could be exerted by either positively influencing STATc
phosphorylation or by negatively acting on PTP3.
To directly study phosphorylation of PTP3 on S448 and S747
we generated Myc-PTP3 overexpressing Ax2 wild-type, pyk32
and phg22 cells, treated them with sorbitol, and performed
Western blot analyses using antibodies specific for phospho-S448
and phospho-S747 PTP3, respectively [7]. In comparison to Ax2/
Myc-PTP3 cells sorbitol-treatment of pyk32/Myc-PTP3 cells
resulted in Myc-PTP3 S448 and S747 phosphorylation (Fig. 5B,
C). The absolute level of phosphorylated S747 was slightly and ofr
S448 considerably lower in pyk32/Myc-PTP3 cells in response to
sorbitol indicating that Pyk3 may somehow contribute to full
inhibition of PTP3. To further investigate the involvement of Pyk3
in the phosphorylation of S448 of PTP3 we expressed GST-
PTP3DCS [12] in bacteria and performed in vitro phosphorylation
assays using the 50% NH4SO4 soluble protein fraction from Ax2
and pyk32 cells. We found that both lysates contain an activity
that is induced by sorbitol and phosphorylates S448 of PTP3 (data
not shown). These results exclude Pyk3 as a specific inhibitor of
PTP3 and suggest that it is involved in the phosphorylation of
STATc as a regulated activator. This could in principle be
analysed using an immunoprecipitation-kinase assay but, given
that any difference might be expected to be only two-fold, it would
be a difficult task.
Next we analysed the possible involvement of Phg2 in the
modulation of STATc activity by inhibition of PTP3. As described
above for Pyk3, Myc-PTP3 overexpressing Ax2 wild-type and
phg22 cells were treated with sorbitol and Western blot analyses
using the phospho-specific PTP3 antibodies were performed. We
observed a similar increase in Myc-PTP3 S448 phosphorylation in
both strains upon sorbitol treatment (Fig. 5D) which was
confirmed by densitometric quantitation of three independent
experiments (Fig. 5F). In contrast, Myc-PTP3 S747 phosphoryla-
tion was nearly completely abolished in the phg22 strain (Fig. 5E).
Quantitation as for the PTP3 S448 specific phosphorylation
Figure 3. Phosphorylation of STATc is reduced in the absence of Pyk3 and Phg2. Ax2 wild-type, pyk32, phg22, and pyk32/phg22cells
were either treated (+) for 15 minutes with 200 mM sorbitol (A), 20 mM 8-Br-cGMP (B), 30 mM BHQ (C) or left untreated (2). Total cell lysates were
prepared, proteins were separated by 10% SDS-PAGE and transferred to nitrocellulose. Total and tyrosine phosphorylated STATc were detected with
the CP22 and 7H3 antibodies, respectively. (D–F): Quantification of phosphorylated STATc in either treated or untreated cells. Band intensities were
determined densitometrically and normalised using the values for total STATc. The amount of phosphorylated STATc of treated Ax2 cells was set to 1
and relative values were calculated for untreated Ax2 cells as well as treated and untreated mutants. The error bars depict standard deviations of
three (D, E) and six (F) independent experiments. (G–I): Staple diagrams depicting the relative amount of phosphorylated STATc from treated (black
part) versus untreated (white part) cells. The total amount of phosphorylated STATc was set to 1 for each comparison and relative values were
calculated.
doi:10.1371/journal.pone.0090025.g003
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revealed a strongly reduced signal in the phg22 strain which was
about three fold weaker as in the Ax2 strain (Fig. 5G). The
remaining weak signal in the phg22 strain could be caused by a
PTP3 S747 specific protein kinase which is either downstream of
Phg2 or acts in parallel to Phg2 or could be due to cross-reactivity
of the PTP3 S747 phospho-specific antibody with non-phosphor-
ylated PTP3. At present we cannot exclude any of these
possibilities. These results also show that at least two distinct
serine/threonine kinases are responsible for the phosphorylation of
PTP3 at S448 and S747.
To investigate a possible direct interaction between Phg2 and
PTP3 we performed pull-down experiments using immunopurified
Myc-PTP3 from phg22 cells and GST-Phg2 purified from
bacteria. The assay was performed with either eluted Myc-PTP3
and GST-Phg2 bound to glutathione beads (Fig. 5H) or Myc-
PTP3 bound to beads and eluted GST-Phg2 (reverse approach,
Fig. 5I). The pull-down experiments showed for both approaches
in vitro binding of Phg2 to PTP3. In the first approach where GST-
Phg2 was bound to glutathione beads most of Myc-PTP3 was
found in the pellet fraction and only a small fraction remained in
the supernatant (Fig. 5H, lanes 8 and 9). In the reverse approach
Myc-PTP3 bound to anti Myc Dynabeads pulled down GST-Phg2
(Fig. 5I, lanes 8 and 9). Soluble GST and GST bound to beads,
respectively, were used as negative controls. Neither Myc-PTP3
bound to GST beads (Fig. 5H, lanes 6 and 7) nor GST bound to
Myc-PTP3 beads (Fig. 5I, lanes 6 and 7). The pull-down results
demonstrate a direct interaction between Myc-PTP3 purified from
phg22 cells and recombinant GST-Phg2 purified from E. coli.
Discussion
STATc, one of four STAT proteins in D. discoideum, is
responsible for a significant part of the transcriptional changes in
response to hyperosmotic conditions [2]. STATc becomes tyrosine
phosphorylated on Tyr922 and nuclear enriched by stress insults,
but also in response to the chlorinated hexaphenone DIF-1 during
development [3,10]. The activation of metazoan STAT proteins is
generally mediated by members of the Janus tyrosine Kinase (JAK)
protein family, whose activity is regulated by growth hormones
and cytokines [25]. Binding of a cytokine to its cognate tyrosine
kinase cell surface receptor triggers autophosphorylation of the
specific receptor-bound JAK. The activated JAK phosphorylates a
tyrosine residue of the receptor that serves as a docking site for the
STAT SH2 domain. The JAK then phosphorylates the bound
Figure 4. Nuclear translocation of STATc is delayed in pyk32, phg22, and pyk32/phg22 cells. (A) Ax2 wild-type, pyk32, phg22, and
pyk32/phg22 cells expressing GFP-STATc were treated with 100 mM sorbitol for the indicated times to induce GFP-STATc nuclear translocation, fixed
with ice-cold methanol, and observed under the fluorescence microscope. Exemplary images of GFP-STATc expressing cells after 0, 3, and 8 min of
treatment are shown and the insets at 3 min show a single exemplary cell for each strain to show prominent nuclear (Ax2), transition i.e. beginning
nuclear (pyk32 and phg22) and clear cytosolic (pyk32/phg22) localisation of GFP-STATc. (B) Quantification of GFP-STATc nuclear translocation in Ax2
wild-type and mutant cells. For each time point, we analysed 150 cells per experiment and determined the number of cells showing either clear
cytosolic (black bar), transition i.e. beginning nuclear (grey bar) or prominent nuclear (white bar) localisation of GFP-STATc. The percentage of cells in
each of these three categories was calculated. Error bars depict standard deviations of two independent experiments.
doi:10.1371/journal.pone.0090025.g004
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Figure 5. Phg2 but not Pyk3 acts upstream of PTP3. (A) Upon hyperosmotic conditions, PTP3 becomes phosphorylated on two serine residues,
S448 and S747, resulting in an inhibition of its phosphatase activity [7]. (B–E) Ax2/Myc-PTP3, pyk32/Myc-PTP3 and phg22/Myc-PTP3 cells were left
untreated (2) or treated (+) with 200 mM sorbitol for 5 min (B, C) or 10 min (D, E). Myc-PTP3 was immunoprecipitated, separated by SDS-PAGE,
transferred to nitrocellulose, and phosphorylated Myc-PTP3 was detected with PTP3 antibodies specific for phospho-serine 448 (B, D) and phospho-
serine 747 (C, E). Total Myc-PTP3 was used as loading control and detected with an anti-Myc antibody (mAb 9E10). (F, G): Quantification of PTP3
phospho-serine 448 (F) and 747 (G) in either treated or untreated cells. Band intensities were determined densitometrically and normalised using the
values for total Myc-PTP3. The amount of serine phosphorylated PTP3 of treated Ax2/Myc-PTP3 cells was set to 1 and relative values were calculated
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STAT at a specific tyrosine close to its C-terminus. This triggers
homo- or hetero-dimerization and nuclear translocation of the
STATs where they control the expression of a large number of
target genes [5,26]. However, the D. discoideum genome does not
encode bona fide tyrosine kinases and there is no JAK ortholog.
Tyrosine phosphorylation in D. discoideum appears to be mediated
by a subset of the Tyrosine Kinase Like (TKL) proteins of which
66 are encoded in the genome [6]. The catalytic sequence motifs
of the TKL protein kinases resemble both, tyrosine and serine/
threonine kinases. In our microarray analysis of Ax2 wild-type and
STATc2 cells five genes encoding TKLs were already differen-
tially regulated 15 min after exposure to sorbitol and their
differential expression was dependent on the presence of STATc
(Table 3; [2]). Based on the assumption of a positive feedback loop
in the STATc signalling cascade we considered these TKLs as
potential upstream regulators of STATc. Notably, the gene
encoding the TKL Pyk2 is among these STATc dependent early
differentially regulated genes. Pyk2 was recently shown to form a
complex with STATc in vitro and in vivo and to directly phosphor-
ylate it. As proposed by Araki et al. Pyk2 is constitutively active
and there is parallel inhibition of the cognate tyrosine phosphatase
PTP3 by phosphorylation of two serine residues, S448 and S747
[7,11].
Our work aimed at the identification of protein kinases apart
from Pyk2, which are involved in STATc regulation. Based on the
early differential regulation in our microarray approach, their
suspected catalytic activity and previously published results, we
chose Pyk3 and Phg2 for further investigation. Pyk3 was originally
identified by screening of a lgt11 expression library with a
phospho-tyrosine specific antibody [23]. More recently it was
found, that in contrast to wild-type cells where STATc phosphor-
ylation in response to DIF-1 peaked after about 3 minutes, Pyk3
knock-out cells displayed persistent STATc phosphorylation which
correlated with aberrant pattern formation during development.
The authors propose that Pyk3 acts upstream of PTP3 but do not
present experimental evidence [27]. Contrary to this hypothesis
we demonstrate that phosphorylation on S448 and S747 of PTP3
does not depend on Pyk3 and that its knock-out results in only
50% lower levels of STATc phosphorylation and a delay in its
nuclear translocation in response to sorbitol as compared to wild-
type cells (Figs. 3, 4, 5). The induction of STATc and STATc
dependent genes was also reduced by only about 50% in pyk32
cells (Fig. 2). Our results are consistent with a model wherein Pyk3
does not inhibit PTP3 but rather directly or indirectly activates
STATc. The remaining lower level of STATc phosphorylation in
the pyk32 strain is we believe due to the activity of Pyk2 (Fig. 3;
[11]; Araki et al., unpublished). The presence of reduced levels of
STATc phosphorylation in the pyk32 strain in response to either
sorbitol, 8-Br-cGMP, or BHQ can be explained if one assumes
that i) Pyk2 is either constitutively active, as proposed by Araki
et al [11], or can also (in addition to DIF-1) be activated through
the cGMP branch and that ii) PTP3 is parallelly inhibited. Our
results are not in agreement with the mode of Pyk3 action
proposed by Lee et al. [27]. The major difference between the two
studies is that Lee et al. investigated development and the DIF-1
response in their pyk32 strain in an Ax4 background [27] while we
analysed the response to hyperosmotic conditions in an Ax2
background.
for untreated Ax2/Myc-PTP3 cells as well as for treated and untreated phg22/Myc-PTP3 cells. The error bars depict standard deviations of three
independent experiments. (H, I): Pull-down assay to investigate the binding of Myc-PTP3 to bacterially expressed GST-Phg2. In the first approach (H)
Myc-PTP3 was expressed in phg22 cells, immunoprecipitated with anti-Myc Dynabeads, and eluted from the beads via a pH shift for binding to GST-
Phg2 bound to glutathione beads. Lane 1: Total cell lysate of Myc-PTP3 expressing phg22 cells; lane 2: Anti-Myc Dynabeads after
immunoprecipitation of Myc-PTP3; lane 3: Myc-PTP3 after elution from anti-Myc Dynabeads; lane 4: GST, purified from bacteria and bound to
glutathione-beads (GST-beads); lane 5: GST-Phg2, purified from bacteria and bound to glutathione-beads (GST-Phg2-beads); lane 6: supernatant after
incubation of Myc-PTP3 with GST-beads; lane 7: pellet after incubation of Myc-PTP3 with GST-beads; lane 8: supernatant after incubation of Myc-PTP3
with GST-Phg2-beads; lane 9: pellet after incubation of Myc-PTP3 with GST-Phg2-beads. In the reverse approach (I) the binding of bacterially
expressed GST-Phg2, which was eluted from glutathione-beads, to Myc-PTP3 bound to anti-Myc Dynabeads (Myc-PTP3-beads) was investigated. Lane
1: Total cell lysate of Myc-PTP3 expressing phg22 cells; lane 2: lysate after immunoprecipitation of Myc-PTP3 with anti-Myc Dynabeads; lane 3: Anti-
Myc Dynabeads with bound Myc-PTP3; lane 4: GST, purified from bacteria and eluted from glutathione-beads; lane 5: GST-Phg2, purified from
bacteria and eluted from glutathione-beads; lane 6: supernatant after incubation of GST with Myc-PTP3-beads; lane 7: pellet after incubation of GST
with Myc-PTP3-beads; lane 8: supernatant after incubation of GST-Phg2 with Myc-PTP3-beads; lane 9: pellet after incubation of GST-Phg2 with Myc-
PTP3-beads. The order of lines from the same immunoblot were digitally re-arranged for illustration purposes to omit dispensable lines.
doi:10.1371/journal.pone.0090025.g005
Figure 6. Model of STATc activation in response to hyperos-
motic conditions. The model is based on results from previously
published studies (green) and from results (blue) and educated
assumptions (red) of the present work. In response to hyperosmolarity
intracellular cGMP and Ca2+ act in parallel as second messengers in
order to activate STATc. GbpC is downstream of cGMP and we postulate
that it acts upstream of Pyk3 and an as yet unidentified STATc protein
kinase (SPK). Phg2 inhibits PTP3 either directly or indirectly by
phosphorylation of S747 and an unknown additional PTP3 serine/
threonine protein kinase (PPK) must be responsible for phosphorylation
of PTP3 at S448. These protein kinases are under control of the Ca2+
branch of the STATc signaling cascade [7]. The model does not
satisfactorily explain all experimental results and we additionally
propose a crosstalk between the two signaling branches (not shown).
See the Discussion section for further details of this model.
doi:10.1371/journal.pone.0090025.g006
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Phg2 belongs to the TKL group but the recombinant kinase
domain was shown to phosphorylate serine and threonine in vitro.
The gene was originally found to be disrupted in a REMI screen
for phagocytosis deficient mutants and the recapitulated knock-out
mutant displayed in addition defects in cellular adhesion, cell
motility, and actin organization [23]. It was also found that Phg2 is
a Rap1 effector and directly interacts with Rap1 via a ras-binding
domain (RBD) in the protein sequence and that the protein binds
PI(4,5)P2 via a novel binding site, which mediates membrane
localization [23,28,29]. Rap1 is implicated in chemotaxis, cell
adhesion and cell polarity and also in the hyperosmotic response
and thought to activate different effectors [30–32]. Phg2 was
identified as a Rap1 effector necessary for cell adhesion but not cell
polarity [29]. We found that in response to hyperosmolarity Phg2
affects STATc phosphorylation and nuclear accumulation (Figs. 3,
4, S5). Furthermore, overexpression of Phg2 in wild-type cells
caused an increase in STATc protein levels (Fig. S6), and in real
time PCR analysis we found that the upregulation of STATc in
response to sorbitol and 8-Br-cGMP is completely dependent on
Phg2 (Fig. 2). Notably, in the phg22 mutant STATc still became
activated and translocated to the nucleus, albeit with a significant
delay (Figs. 3, 4). We propose that Phg2 is required for the nuclear
translocation of an additional protein that is needed for the
transcriptional activity of STATc. Further work is needed to
elucidate the identity of this factor. Another result of the real time
PCR analysis was that the fold changes of the differentially
regulated genes were always lower in response to 8-Br-cGMP and
BHQ than to sorbitol (Fig. 2). This result suggests that activation of
both the cGMP and the Ca2+ branch of STATc signalling is
needed for a full transcriptional response. In previous studies Phg2
had not been implicated in STATc signaling and we show for the
first time that it also plays an important role in the hyperosmotic
response. Its phosphorylation specificity for Ser/Thr excluded
STATcTyr922 as target [23]. Therefore, we investigated if Phg2
could possibly act on PTP3, the constitutive active tyrosine
phosphatase which counterbalances STATc phosphorylation [7].
Using phosphorylation specific antibodies we provide evidence
that phosphorylation of PTP3S747 but not PTP3S448 is significantly
reduced in the phg22 mutant (Fig. 5D, E, F, G). Furthermore, we
could show that myc-PTP3 from phg22 cells pulled down
recombinant GST-Phg2 and vice versa (Figs. 5H, I). However,
and despite several attempts, we could so far not directly
phosphorylate PTP3 with Phg2. Thus, Phg2 might activate a
downstream protein kinase which could act on PTP3. Alterna-
tively, it is possible that recombinant Phg2 is enzymatically not
active but nevertheless able to strongly bind PTP3 and that we
need an additional factor, as for example active Rap1, to activate
the protein kinase. Further work is needed to clarify this issue.
In conclusion, our study provides additional insights into the
STATc activation pathway in D. discoideum that are illustrated in a
flow chart (Fig. 6). This figure depicts a possible STATc activation
mechanism, which is based on published results (green), results
(blue) and educated assumptions (red) from the present study.
STATc becomes activated upon hyperosmolarity via two signaling
branches, the cGMP-dependent and the Ca2+-dependent branch,
and an increase in intracellular cGMP levels activate GbpC in the
cGMP branch [7]. The downstream target of Ca2+ is not yet
known. Recently it was shown that phosphorylation of PTP3S747
and PTP3S448 could not be triggered by cGMP but was dependent
on Ca2+ [7]. We provide evidence that Phg2 acts upstream of
PTP3 and either directly phosphorylates S747 or activates another
downstream protein kinase which then phosphorylates S747.
Phosphorylation of PTP3S448 was unchanged in the phg22 mutant
and we could show that Pyk3 is not responsible for it (Fig. 5).
Therefore, the S448 phosphorylation must be accomplished by an
as yet unidentified PTP3 ser/thr protein kinase (PPK). As a
consequence PTP3 is only partially inhibited in response to
sorbitol in the phg22 mutant which explains the reduced STATc
phosphorylation in this mutant. The fact that the phenotype of the
pyk32/phg22 double mutant was in all our experiments more
severe than either of the single mutants supports the hypothesis
that neither Pyk3 acts upstream of Phg2 nor vice versa, but that
both proteins act in parallel to modulate STATc (Figs. 3–5). We
have obtained reduced STATc phosphorylation in two indepen-
dently generated pyk32 mutants (labs of JGW and LE, not shown).
Therefore, we postulate that the reduced level of p-STATc in the
pyk32 strain in response to sorbitol and 8-Br-cGMP but not BHQ
is due to the presence of another, as yet unidentified, STATc
protein kinase (SPK) downstream of cGMP. The exact target and
action of Pyk3 has still to be elucidated and STATc is an attractive
candidate. The STATc phosphorylation patterns (Fig. 3) can be
explained with Pyk3 acting downstream of cGMP and in parallel
to the postulated SPK. This requires that the activity of the as yet
unknown SPK is induced via cGMP but not via the Ca2+ liberator
BHQ. It is of particular interest, that the TKL Pyk2 was recently
shown to directly phosphorylate STATc in response to DIF-1 [11].
Thus, it is possible that the reduced level of p-STATc in the pyk32
strain in response to sorbitol and 8-Br-cGMP but not BHQ is due
to Pyk2. It should be noted that the model does not fully explain all
details of our results, rather it presents a simplified working
hypothesis that explains the major aspects of STATc regulation in
response to hyperosmolarity. As hypothesized for the transcrip-
tional regulation (Fig. 2) we think that subtle discrepancies in
STATc phosphorylation in response to sorbitol, 8-Br-cGMP or
BHQ (Fig. 3) to expected changes are due to cross talk between the
two branches. Alternatively, another pathway might be activated
by sorbitol in addition to cGMP and Ca2+. Future work will
address these possibilities and elucidate additional components of
the complex D. discoideum STATc signaling cascade that are
together responsible for optimal STATc activation in response to
different cues.
Supporting Information
Figure S1 Generation of knock-out mutants. (A) The
phg22 strain was generated by replacement of a 2.9 kbp genomic
fragment of the phg2 gene that contained part of the tyrosine kinase
domain coding sequence with the targeting construct containing
the blasticidin resistance cassette flanked by loxP recombination
sites. The targeting construct with the blasticidin resistance
cassette is shown on top, the genomic sequence of phg2 before
the recombination event in the middle, and after the recombina-
tion event at the bottom. BamHI, PstI, HindIII, SalI: DNA
restriction enzyme sites that were used for the generation of the
targeting construct. A8P: Actin 8 promoter. A15T: Actin 15
terminator. Bsr: blasticidin resistance gene. The illustration does
not reflect the true scale of actual parts of the disruption vector. (B)
The pyk32 strain was generated by replacement of a 2.37 kbp
genomic fragment of the pyk3 gene with the targeting strategy as
described for phg22. The pyk32/phg22 double knock-out strain
was generated by transforming the pyk32 strain after transient
expression of the cre recombinase (restored blasticidin sensitivity) with
the targeting construct for phg2 (shown at the bottom).
(PDF)
Figure S2 Domain structure of D. discoideum Pyk3 and
Phg2. The protein sequences of Pyk3 (DDB_G0289001) and
Phg2 (DDB_G0283699) were analysed with SMART (http://
smart.embl-heidelberg.de/) to elucidate their domain architecture.
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STYKc: possible dual-specificity Ser/Thr/Tyr protein kinase
domain; green rectangles: coiled coil regions; lilac rectangles:
segments of low compositional complexity; aa: amino acids.
(PDF)
Figure S3 Analysis of the generated pyk32, phg22 and
pyk32/phg22 knock-out strains. (A) Reverse transcription
PCR using primer pairs that amplify small fragments of the 39-end
of the pyk3, phg2, and dstc cDNA, respectively. dstc was used as a
positive control. (B) Western blot analysis of total cell lysates of
Ax2 wild-type, pyk32, phg22, and pyk32/phg22 cells. Proteins
were separated by SDS-PAGE, transferred to nitrocellulose and
Western blot analyses with polyclonal pyk3 and phg2 antibodies
were performed. Severin was used as loading control and detected
with a monoclonal severin antibody (mAb 101-460-2). Please note
that the weak band in the pyk32 strain (*) is due to cross-reaction
of the Pyk3 antibody. A similar cross-reaction with this antibody
was also seen in the independently generated pyk32 mutant in the
lab of J.G. Williams (data not shown).
(PDF)
Figure S4 Western Blot analysis of GFP-STATc expres-
sion in Ax2, pyk32, phg22, and pyk32/phg22 cells. The
expression of GFP-STATc was monitored by Western blot
analysis of total cell lysates with a monoclonal GFP antibody
(mAb K3-184-2). Actin was used as loading control and detected
with a monoclonal actin antibody (mAb Act1-7).
(PDF)
Figure S5 Immunofluorescence analysis of GFP-STATc
nuclear translocation in GFP-STATc expressing Ax2,
pyk32, phg22, and pyk32/phg22 cells. (A) Ax2/GFP-
STATc, (B) pyk32/GFP-STATc, (C) phg22/GFP-STATc, (D)
pyk32/phg22/GFP-STATc. Log phase cells were washed twice
with Soerensen buffer, transferred to coverslips and allowed to
settle for 15 minutes. After treatment with 100 mM sorbitol for 0,
2, 3, 4, 5 and 8 minutes, cells were fixed with methanol and the
nuclear translocation of GFP-STATc was analysed with a
fluorescence microscope. Top: Exemplary images. Scale bar:
10 mm. Bottom: Quantification of GFP-STATc nuclear translo-
cation in Ax2 wild-type and mutant cells. For each time point, we
analysed 150 cells per experiment. The number of cells showing
either clear cytosolic (black bar) beginning nuclear (grey bar) or
prominent nuclear (white bar) localization of GFP-STATc was
determined and the percentage of cells in each of these three
categories was calculated. The error bars depict standard
deviations of two independent experiments.
(PDF)
Figure S6 Overexpression of Phg2 causes a strong
increase in STATc protein levels. Ax2 wild-type and Ax2/
Myc-Phg2 expressing cells were either treated with 200 mM
sorbitol for 15 min or left untreated and total cell lysates were
prepared. Proteins were separated by SDS-PAGE and transferred
to nitrocellulose. Western blot analysis was performed with
antibodies specific for total (7H3) and tyrosine phosphorylated
STATc (CP22), for Myc-Phg2 (mAb 9E10), and for endogenous
Phg2 (polyclonal Phg2 antibody). Actin was used as loading
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